22UAy.DE
Latest Trade
254.30EURChange
-21.00(-7.63%)Volume
218,857Today's Range
-
267.6052 Week Range
-
395.00As of on the NASDAQ ∙ Minimum 15 minute delay
Previous Close | 275.30 |
|---|---|
Open | 266.50 |
Volume | 218,857 |
3M AVG Volume | 88.04 |
Today's High | 267.60 |
Today's Low | 251.10 |
52 Week High | 395.00 |
52 Week Low | 65.50 |
Shares Out (MIL) | 241.52 |
Market Cap (MIL) | 80,874.55 |
Forward P/E | 8.18 |
Dividend (Yield %) | -- |
CDC Statement On ACIP Booster Recommendations
FDA Says Authorizes Booster Dose Of Pfizer-Biontech Covid-19 Vaccine For Certain Populations
Pfizer Inc And Biontech Expand Collaboration With U.S. To Provide Covid-19 Vaccine Doses At Not-For-Profit Price For Donation To Poorest Countries
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
Industry
Biotechnology & Drugs
Price To Earnings (TTM) | 17.42 |
|---|---|
Price To Sales (TTM) | 8.89 |
Price To Book (MRQ) | 12.54 |
Price To Cash Flow (TTM) | 16.75 |
Total Debt To Equity (MRQ) | 21.87 |
LT Debt To Equity (MRQ) | 8.87 |
Return on Investment (TTM) | 120.65 |
Return on Equity (TTM) | 80.46 |
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.